ES521895A0 - Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. - Google Patents
Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.Info
- Publication number
- ES521895A0 ES521895A0 ES521895A ES521895A ES521895A0 ES 521895 A0 ES521895 A0 ES 521895A0 ES 521895 A ES521895 A ES 521895A ES 521895 A ES521895 A ES 521895A ES 521895 A0 ES521895 A0 ES 521895A0
- Authority
- ES
- Spain
- Prior art keywords
- espiroimidazolidina
- benzoazacicloalquil
- pharmaceutically
- well
- organic bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
ES521895A0 true ES521895A0 (es) | 1984-06-16 |
ES8405796A1 ES8405796A1 (es) | 1984-06-16 |
Family
ID=9273425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521895A Expired ES8405796A1 (es) | 1982-04-27 | 1983-04-27 | Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS5910584A (es) |
KR (1) | KR840004428A (es) |
AT (1) | ATA125383A (es) |
AU (1) | AU1395383A (es) |
BE (1) | BE896572A (es) |
DD (1) | DD209833A5 (es) |
DE (1) | DE3315106A1 (es) |
DK (1) | DK183583A (es) |
ES (1) | ES8405796A1 (es) |
FR (1) | FR2525603A1 (es) |
GB (1) | GB2133401B (es) |
GR (1) | GR78481B (es) |
IL (1) | IL68497A0 (es) |
IT (1) | IT1167123B (es) |
LU (1) | LU84770A1 (es) |
MA (1) | MA19783A1 (es) |
NL (1) | NL8301476A (es) |
NO (1) | NO831473L (es) |
OA (1) | OA07412A (es) |
PT (1) | PT76595B (es) |
SE (1) | SE8302347L (es) |
ZA (1) | ZA832927B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
PL2332921T3 (pl) | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
EP2332920A3 (en) | 2003-06-17 | 2011-12-21 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
NZ555981A (en) | 2004-12-21 | 2011-01-28 | Arena Pharm Inc | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
NZ555482A (en) | 2004-12-23 | 2011-01-28 | Arena Pharm Inc | Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use |
EP2471779A1 (en) | 2006-04-03 | 2012-07-04 | Arena Pharmaceuticals, Inc. | Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
WO2012030957A2 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
KR20180118801A (ko) | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태 |
CA2808909A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
BR112015007779A2 (pt) | 2012-10-09 | 2017-07-04 | Arena Pharm Inc | célula de fluxo de permeabilidade e sistema de condutância hidráulica |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ATA125383A (de) | 1986-05-15 |
SE8302347L (sv) | 1983-10-28 |
DE3315106A1 (de) | 1983-11-03 |
KR840004428A (ko) | 1984-10-15 |
LU84770A1 (fr) | 1984-11-28 |
SE8302347D0 (sv) | 1983-04-26 |
DK183583A (da) | 1983-10-28 |
AU1395383A (en) | 1983-11-03 |
BE896572A (fr) | 1983-10-26 |
IT1167123B (it) | 1987-05-13 |
FR2525603B1 (es) | 1984-09-14 |
DD209833A5 (de) | 1984-05-23 |
NO831473L (no) | 1983-10-28 |
GR78481B (es) | 1984-09-27 |
NL8301476A (nl) | 1983-11-16 |
PT76595B (fr) | 1986-01-21 |
FR2525603A1 (fr) | 1983-10-28 |
PT76595A (fr) | 1983-05-01 |
IL68497A0 (en) | 1983-07-31 |
ES8405796A1 (es) | 1984-06-16 |
MA19783A1 (fr) | 1983-12-31 |
JPS5910584A (ja) | 1984-01-20 |
IT8348155A0 (it) | 1983-04-26 |
GB8311508D0 (en) | 1983-06-02 |
GB2133401A (en) | 1984-07-25 |
OA07412A (fr) | 1984-11-30 |
ZA832927B (en) | 1984-06-27 |
GB2133401B (en) | 1985-10-23 |
DK183583D0 (da) | 1983-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8322801A0 (it) | Procedimento per la produzione di idrocarburi. | |
ES521895A0 (es) | Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. | |
ES556363A0 (es) | Procedimiento para la produccion de tiazoles., | |
IT8220262A0 (it) | Procedimento per la ossidrilazione di idrocarburi aromatici. | |
IT8719199A0 (it) | Procedimento per la produzione di benzina. | |
ES510167A0 (es) | Procedimiento para la produccion de n-acilo-polipeptidos. | |
IT8222414A0 (it) | Processo per la preparazione dicomposti organici. | |
IT7926935A0 (it) | Procedimento eterogeneo per lapreparazione di 1,1-diesteri. | |
IT8023087A0 (it) | Procedimento per la produzione di p-cloroalchilbenzene. | |
IT8023163A0 (it) | Processo per la preparazione dicomposti organici carbossilati. | |
IT7927658A0 (it) | Processo per la preparazione di idrocarburi. | |
IT7926560A0 (it) | Procedimento perfezionato per lapreparazione di idroperossidi aromatici. | |
IT7923692A0 (it) | Procedimento per la preparazione di poliolefine. | |
IT7925114A0 (it) | Procedimento per la fabbricazione di chiodi. | |
IT8523143A0 (it) | Procedimento per il consolidamento di terreni. | |
IT7927659A0 (it) | Processo per la preparazione di idrocarburi. | |
ES510596A0 (es) | Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo. | |
ES503485A0 (es) | Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas | |
ES542835A0 (es) | Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer. | |
ES2016964B3 (es) | Procedimiento para la preparacion de bitumen. | |
IT8122146A0 (it) | Procedimento per la produzione di mercapto-2-etanolo-1. | |
ES545018A0 (es) | Procedimiento de preparar agentes de fluoracion de compuestos organicos. | |
NO161911C (no) | Fremgangsmaate for fremstilling av sulfonater. | |
DK212783D0 (da) | Fremgangsmade til fremstilling af melasseholdige, mineralske fodermidler | |
IT8021231A0 (it) | Procedimento per la preparazione di 2-amminopirazine sostituite. |